Global Perspectives on Hepatitis B Management in Pregnancy

Description

This interactive discussion explores the complexities of managing hepatitis B in pregnancy, highlighting the key differences in approaches between Asia and Western countries. Presentation topics include: insights into region-specific guidelines; antiviral therapy options; neonatal immunoprophylaxis strategies; and the influence of cultural and health care system factors on care delivery. By comparing practices across regions, the session provides practical knowledge to optimize outcomes for pregnant women with hepatitis B and their newborns in diverse clinical settings.

Journey Maps

Presentations

9:45 AM - 10:00 AM
Nov 09 2025
Washington, D.C.

American Association for the Study of Liver Diseases Guidance: Management of Hepatitis B Virus in Pregnancy

Tatyana Kushner, MD, MSCE, Presenter
Hepatitis
10:00 AM - 10:15 AM
Nov 09 2025
Washington, D.C.

Indian National Association for Study of the Liver Guidance: Management of Hepatitis B Virus in Pregnancy

Anil Dr Arora, MD, FAASLD, Presenter
Hepatitis
10:15 AM - 10:20 AM
Nov 09 2025
Washington, D.C.

Case Presentation for Panel Discussion

Calvin Q Pan, MD, MACP, FAASLD, Presenter
Hepatitis

Objectives

  • Describe the unique challenges and considerations in managing hepatitis B during pregnancy and postnatal care.
  • Compare the differences in guidelines and practices for hepatitis B management in pregnancy between Asia and Western countries.
  • Evaluate the role of antiviral therapy during pregnancy to prevent vertical transmission of hepatitis B.
  • Analyze the impact of cultural, economic, and health care system differences on the management of hepatitis B in pregnancy.